telmisartan has been researched along with sodium arsenite in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Mulhim, AS; Fouad, AA; Jresat, I | 1 |
| Majumdar, A; Nirwane, A; Pawar, V | 1 |
2 other study(ies) available for telmisartan and sodium arsenite
| Article | Year |
|---|---|
Telmisartan treatment attenuates arsenic-induced hepatotoxicity in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arsenites; Benzimidazoles; Benzoates; Caspase 3; Chemical and Drug Induced Liver Injury; Environmental Pollutants; Glutathione; Immunohistochemistry; Lipid Peroxidation; Liver; Liver Function Tests; Male; Mice; NF-kappa B; Selenium; Sodium Compounds; Telmisartan; Zinc | 2012 |
Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
Topics: Animals; Aorta, Thoracic; Arsenites; Benzimidazoles; Benzoates; Cardiovascular Agents; Cholesterol; Endothelium, Vascular; Fatty Acids, Omega-3; Glyburide; KATP Channels; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oxidative Stress; Rats, Wistar; Sodium Compounds; Telmisartan; Thiobarbituric Acid Reactive Substances; Triglycerides; Vascular Diseases; Vasodilation | 2015 |